{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:18:58Z","timestamp":1776943138640,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ym012655h"],"award-info":[{"award-number":["JP22ym012655h"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"TOPPAN INC.","award":["PC86180005"],"award-info":[{"award-number":["PC86180005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The protracted preclinical stage of Alzheimer\u2019s disease (AD) provides the opportunity for early intervention to prevent the disease; however, the lack of minimally invasive and easily detectable biomarkers and their measurement technologies remain unresolved. Extracellular vesicles (EVs) are nanosized membrane vesicles released from a variety of cells and play important roles in cell\u2013cell communication. Neuron-derived and ganglioside-enriched EVs capture amyloid-\u00df protein, a major AD agent, and transport it into glial cells for degradation; this suggests that EVs influence A\u00df accumulation in the brain. EV heterogeneity, however, requires the use of a highly sensitive technique for measuring specific EVs in biofluid. In this study, immuno-digital invasive cleavage assay (idICA) was developed for quantitating target-intact EVs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>EVs were captured onto ganglioside GM1-specific cholera toxin B subunit (CTB)-conjugated magnetic beads and detected with a DNA oligonucleotide-labeled A\u00df antibody. Fluorescence signals for individual EVs were then counted using an invasive cleavage assay (ICA). This idICA examines the A\u00df-bound and GM1-containing EVs isolated from the culture supernatant of human APP-overexpressing N2a (APP-N2a) cells and APP  transgenic\u00a0mice sera.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The idICA quantitatively detected A\u00df-bound and GM1-containing EVs isolated from culture supernatants of APP-N2a cells and sera of AD model mice. The idICA levels of A\u00df-associated EVs in blood gradually increased from 3- to 12-month-old mice, corresponding to the progression of A\u00df accumulations in the brain of AD model mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The present findings suggest that peripheral EVs harboring A\u00df and GM1 reflect A\u00df burden in mice. The idICA is a valuable tool for easy quantitative detection of EVs as an accessible biomarker for preclinical AD diagnosis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-01073-w","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T01:02:23Z","timestamp":1664758943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Immuno-digital invasive cleavage assay for analyzing Alzheimer\u2019s amyloid \u00df-bound extracellular vesicles"],"prefix":"10.1186","volume":"14","author":[{"given":"Kohei","family":"Yuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Monde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Hirase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"1073_CR1","doi-asserted-by":"publisher","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione S, Monyror J, Galleguillos D, Steinberg N, Kadam V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci. 2020;14:572965.","journal-title":"Front Neurosci"},{"key":"1073_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10719-015-9579-5","volume":"32","author":"K Yanagisawa","year":"2015","unstructured":"Yanagisawa K. GM1 ganglioside and Alzheimer\u2019s disease. Glycoconj J. 2015;32:87\u201391.","journal-title":"Glycoconj J"},{"key":"1073_CR3","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.bbamem.2008.07.028","volume":"1778","author":"N Yamamoto","year":"2008","unstructured":"Yamamoto N, Matsubara T, Sato T, Yanagisawa K. Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis. Biochim Biophys Acta. 2008;1778:2717\u201326.","journal-title":"Biochim Biophys Acta"},{"key":"1073_CR4","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1021\/bi0255874","volume":"41","author":"A Kakio","year":"2002","unstructured":"Kakio A, Nishimoto S-I, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid. Biochemistry. 2002;41:7385\u201390.","journal-title":"Biochemistry"},{"key":"1073_CR5","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/nm1095-1062","volume":"1","author":"K Yanagisawa","year":"1995","unstructured":"Yanagisawa K, Odaka A, Suzuki N, Ihara Y. GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer\u2019s disease. Nat Med. 1995;1:1062\u20136.","journal-title":"Nat Med"},{"key":"1073_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuron.2014.02.027","volume":"82","author":"S Hong","year":"2014","unstructured":"Hong S, Ostaszewski BL, Yang T, O\u2019Malley TT, Jin M, Yanagisawa K, et al. Soluble A\u03b2 oligomers are rapidly sequestered from brain ISF in vivo and bind GM1 ganglioside on cellular membranes. Neuron. 2014;82:308\u201319.","journal-title":"Neuron"},{"key":"1073_CR7","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci USA. 2006;103:11172\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1073_CR8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19:213\u201328.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1073_CR9","doi-asserted-by":"publisher","first-page":"10977","DOI":"10.1074\/jbc.M111.324616","volume":"287","author":"K Yuyama","year":"2012","unstructured":"Yuyama K, Sun H, Mitsutake S, Igarashi Y. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-\u03b2 by microglia. J Biol Chem. 2012;287:10977\u201389.","journal-title":"J Biol Chem"},{"key":"1073_CR10","doi-asserted-by":"publisher","first-page":"24488","DOI":"10.1074\/jbc.M114.577213","volume":"289","author":"K Yuyama","year":"2014","unstructured":"Yuyama K, Sun H, Sakai S, Mitsutake S, Okada M, Tahara H, et al. Decreased amyloid-\u03b2 pathologies by intracerebral loading of glycosphingolipid-enriched exosomes in Alzheimer model mice. J Biol Chem. 2014;289:24488\u201398.","journal-title":"J Biol Chem"},{"key":"1073_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.febslet.2014.11.027","volume":"589","author":"K Yuyama","year":"2015","unstructured":"Yuyama K, Sun H, Usuki S, Sakai S, Hanamatsu H, Mioka T, et al. A potential function for neuronal exosomes: sequestering intracerebral amyloid-\u03b2 peptide. FEBS Lett. 2015;589:84\u20138.","journal-title":"FEBS Lett"},{"key":"1073_CR12","doi-asserted-by":"publisher","first-page":"8653","DOI":"10.1523\/JNEUROSCI.1429-16.2016","volume":"36","author":"MB Dinkins","year":"2016","unstructured":"Dinkins MB, Enasko J, Hernandez C, Wang G, Kong J, Helwa I, et al. Neutral sphingomyelinase-2 deficiency ameliorates alzheimer\u2019s disease pathology and improves cognition in the 5XFAD mouse. J Neurosci. 2016;36:8653\u201367.","journal-title":"J Neurosci"},{"key":"1073_CR13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/90290","volume":"19","author":"PS Eis","year":"2001","unstructured":"Eis PS, Olson MC, Takova T, Curtis ML, Olson SM, Vener TI, et al. An invasive cleavage assay for direct quantitation of specific RNAs. Nat Biotechnol. 2001;19:673\u20136.","journal-title":"Nat Biotechnol"},{"key":"1073_CR14","doi-asserted-by":"publisher","first-page":"108081","DOI":"10.1016\/j.neuropharm.2020.108081","volume":"185","author":"H Hampel","year":"2021","unstructured":"Hampel H, Vergallo A, Caraci F, Cuello AC, Lemercier P, Vellas B, et al. Future avenues for Alzheimer\u2019s disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery. Neuropharmacology. 2021;185:108081.","journal-title":"Neuropharmacology"},{"key":"1073_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fphar.2019.00310","volume":"10","author":"H Hampel","year":"2019","unstructured":"Hampel H, Goetzl EJ, Kapogiannis D, Lista S, Vergallo A. Biomarker-drug and liquid biopsy co-development for disease staging and targeted therapy: cornerstones for Alzheimer\u2019s precision medicine and pharmacology. Front Pharmacol. 2019;10:310.","journal-title":"Front Pharmacol"},{"key":"1073_CR16","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.7150\/thno.39486","volume":"10","author":"B Pang","year":"2020","unstructured":"Pang B, Zhu Y, Ni J, Thompson J, Malouf D, Bucci J, et al. Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis. Theranostics. 2020;10:2309\u201326.","journal-title":"Theranostics"},{"key":"1073_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/jjco\/hyy120","volume":"48","author":"Y Yoshioka","year":"2018","unstructured":"Yoshioka Y, Katsuda T, Ochiya T. Extracellular vesicles and encapusulated miRNAs as emerging cancer biomarkers for novel liquid biopsy. Jpn J Clin Oncol. 2018;48:869\u201376.","journal-title":"Jpn J Clin Oncol"},{"key":"1073_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nrneurol.2016.68","volume":"12","author":"AG Thompson","year":"2016","unstructured":"Thompson AG, Gray E, Heman-Ackah SM, M\u00e4ger I, Talbot K, El Andaloussi S, et al. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol. 2016;12:346\u201357.","journal-title":"Nat Rev Neurol"},{"key":"1073_CR19","doi-asserted-by":"publisher","first-page":"041503","DOI":"10.1063\/1.5087690","volume":"13","author":"FS Iliescu","year":"2019","unstructured":"Iliescu FS, Poenar DP, Yu F, Ni M, Chan KH, Cima I, et al. Recent advances in microfluidic methods in cancer liquid biopsy. Biomicrofluidics. 2019;13:041503.","journal-title":"Biomicrofluidics"},{"key":"1073_CR20","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1074\/jbc.M606202200","volume":"282","author":"N Yamamoto","year":"2007","unstructured":"Yamamoto N, Matsubara E, Maeda S, Minagawa H, Takashima A, Maruyama W, et al. A ganglioside-induced toxic soluble Abeta assembly. Its enhanced formation from Abeta bearing the Arctic mutation. J Biol Chem. 2007;282:2646\u201355.","journal-title":"J Biol Chem"},{"key":"1073_CR21","first-page":"73","volume":"42","author":"WE Van Heyningen","year":"1976","unstructured":"Van Heyningen WE, Van Heyningen S, King CA. The nature and action of cholera toxin. Ciba Found Symp. 1976;42:73\u201388.","journal-title":"Ciba Found Symp"},{"key":"1073_CR22","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367:eaau6977.","journal-title":"Science"},{"key":"1073_CR23","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","volume":"40","author":"G De Rubis","year":"2019","unstructured":"De Rubis G, Krishnan SR, Bebawy M. Liquid biopsies in cancer diagnosis, monitoring, and prognosis. Trends Pharmacol Sci. 2019;40:172\u201386.","journal-title":"Trends Pharmacol Sci"},{"key":"1073_CR24","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jalz.2014.06.008","volume":"11","author":"MS Fiandaca","year":"2015","unstructured":"Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al. Identification of preclinical Alzheimer\u2019s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015;11:600\u20137.","journal-title":"Alzheimers Dement"},{"key":"1073_CR25","doi-asserted-by":"publisher","first-page":"9269","DOI":"10.1523\/JNEUROSCI.0147-18.2019","volume":"39","author":"AF Hill","year":"2019","unstructured":"Hill AF. Extracellular vesicles and neurodegenerative diseases. J Neurosci. 2019;39:9269\u201373.","journal-title":"J Neurosci"},{"key":"1073_CR26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1001\/jama.2019.4782","volume":"322","author":"Z Arvanitakis","year":"2019","unstructured":"Arvanitakis Z, Shah RC, Bennett DA. Diagnosis and management of dementia: review. JAMA. 2019;322:1589\u201399.","journal-title":"JAMA"},{"key":"1073_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-020-02254-3","volume":"141","author":"JC Polanco","year":"2021","unstructured":"Polanco JC, Hand GR, Briner A, Li C, G\u00f6tz J. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathol. 2021;141:235\u201356.","journal-title":"Acta Neuropathol"},{"key":"1073_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1134\/S0006297909030018","volume":"74","author":"NV Prokazova","year":"2009","unstructured":"Prokazova NV, Samovilova NN, Gracheva EV, Golovanova NK. Ganglioside GM3 and its biological functions. Biochemistry (Mosc). 2009;74:235\u201349.","journal-title":"Biochemistry (Mosc)"},{"key":"1073_CR29","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0005-2760(73)90055-6","volume":"296","author":"G Tettamanti","year":"1973","unstructured":"Tettamanti G, Bonali F, Marchesini S, Zambotti V. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim Biophys Acta. 1973;296:160\u201370.","journal-title":"Biochim Biophys Acta"},{"key":"1073_CR30","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1182\/blood-2003-03-0871","volume":"102","author":"A de Gassart","year":"2003","unstructured":"de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M. Lipid raft-associated protein sorting in exosomes. Blood. 2003;102:4336\u201344.","journal-title":"Blood"},{"key":"1073_CR31","doi-asserted-by":"publisher","first-page":"102839","DOI":"10.1016\/j.isci.2021.102839","volume":"24","author":"A Matsumoto","year":"2021","unstructured":"Matsumoto A, Takahashi Y, Ogata K, Kitamura S, Nakagawa N, Yamamoto A, et al. Phosphatidylserine-deficient small extracellular vesicle is a major somatic cell-derived sEV subpopulation in blood. iScience. 2021;24:102839.","journal-title":"iScience"},{"key":"1073_CR32","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.bbapap.2018.09.010","volume":"1867","author":"W Michno","year":"2019","unstructured":"Michno W, Wehrli PM, Zetterberg H, Blennow K, Hanrieder J. GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology. Biochim Biophys Acta Proteins Proteom. 2019;1867:458\u201367.","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"key":"1073_CR33","doi-asserted-by":"publisher","first-page":"24985","DOI":"10.1074\/jbc.M100252200","volume":"276","author":"A Kakio","year":"2001","unstructured":"Kakio A, Nishimoto S-I, Yanagisawa K, Kozutsumi Y, Matsuzaki K. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid beta-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem. 2001;276:24985\u201390.","journal-title":"J Biol Chem"},{"key":"1073_CR34","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.neurobiolaging.2014.02.012","volume":"35","author":"MB Dinkins","year":"2014","unstructured":"Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer\u2019s disease. Neurobiol Aging. 2014;35:1792\u2013800.","journal-title":"Neurobiol Aging"},{"key":"1073_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jnc.13514","volume":"137","author":"C Falker","year":"2016","unstructured":"Falker C, Hartmann A, Guett I, Dohler F, Altmeppen H, Betzel C, et al. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem. 2016;137:88\u2013100.","journal-title":"J Neurochem"},{"key":"1073_CR36","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.jalz.2017.06.2266","volume":"13","author":"V Ovod","year":"2017","unstructured":"Ovod V, Ramsey KN, Mawuenyega KG, Bollinger JG, Hicks T, Schneider T, et al. Amyloid \u03b2 concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement. 2017;13:841\u20139.","journal-title":"Alzheimers Dement"},{"key":"1073_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249\u201354.","journal-title":"Nature"},{"key":"1073_CR38","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1001\/jamaneurol.2021.3180","volume":"78","author":"S Janelidze","year":"2021","unstructured":"Janelidze S, Teunissen CE, Zetterberg H, Allu\u00e9 JA, Sarasa L, Eichenlaub U, et al. Head-to-head comparison of 8 plasma amyloid-\u03b2 42\/40 assays in Alzheimer disease. JAMA Neurol. 2021;78:1375\u201382.","journal-title":"JAMA Neurol"},{"key":"1073_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nbt.2886","volume":"32","author":"H Im","year":"2014","unstructured":"Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014;32:490\u20135.","journal-title":"Nat Biotechnol"},{"key":"1073_CR40","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1021\/acsnano.5b07584","volume":"10","author":"S Jeong","year":"2016","unstructured":"Jeong S, Park J, Pathania D, Castro CM, Weissleder R, Lee H, et al. Integrated magneto-electrochemical sensor for exosome analysis. ACS Nano. 2016;10:1802\u20139.","journal-title":"ACS Nano"},{"issue":"Suppl 2","key":"1073_CR41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s40120-019-00164-5","volume":"8","author":"D Li","year":"2019","unstructured":"Li D, Mielke MM. An update on blood-based markers of Alzheimer\u2019s disease using the SiMoA platform. Neurol Ther. 2019;8(Suppl 2):73\u201382.","journal-title":"Neurol Ther"},{"key":"1073_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ymeth.2020.02.002","volume":"177","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, Lin W, Chen M, Hersh SW, Emili A, Xia W, et al. Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids. Methods. 2020;177:35\u201349.","journal-title":"Methods"},{"key":"1073_CR43","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.3390\/cells9091959","volume":"9","author":"S Muraoka","year":"2020","unstructured":"Muraoka S, Jedrychowski MP, Yanamandra K, Ikezu S, Gygi SP, Ikezu T. Proteomic profiling of extracellular vesicles derived from cerebrospinal fluid of Alzheimer\u2019s disease patients: a pilot study. Cells. 2020;9:1959.","journal-title":"Cells"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01073-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01073-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T01:02:29Z","timestamp":1664758949000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01073-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1073"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01073-w","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"31 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experimental protocol was approved by the Hokkaido University Animal Care Committees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors TH, MN, and YM are employees of TOPPAN INC., Japan.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}